The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
MicroRNA Expression Characterizes Oligometastasis(es)
Open accessAbstract
BACKGROUND: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤ 5 cumulative metastasis(es), termed oligometastases. In contrast to widespread polymetastases, oligometastatic patients may benefit from metastasis-directed local treatments. However, many patients who initially present with oligometastases progress to polymetastases. Predictors of progression could improve patient selection for metastasis-directed therapy. METHODS: Here, we identified patterns of microRNA expression of tumor samples from oligometastatic patients treated with high-dose radiotherapy. RESULTS: Patients who failed to develop polymetastases are characterized by unique prioritized features of a microRNA classifier that includes the microRNA-200 family. We created an oligometastatic-polymetastatic xenograft model in which the patient-derived microRNAs discriminated between the two metastatic outcomes. MicroRNA-200c enhancement in an oligometastatic cell line resulted in polymetastatic progression. CONCLUSIONS: These results demonstrate a biological basis for oligometastases and a potential for using microRNA expression to identify patients most likely to remain oligometastatic after metastasis-directed treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Self-citationDistant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems
Hand, D. J., & Till, R. J. (2001) · Machine Learning · doi:10.1023/a:1010920819831 · Cited by 2,276
Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
ADE-4: a multivariate analysis and graphical display software
Thioulouse, J., Chessel, D., Dole´dec, S., & Olivier, J.-M. (1997) · Statistics and Computing · doi:10.1023/a:1018513530268 · Cited by 1,620
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Liver resection for colorectal metastases.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.938 · Cited by 1,284
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
Tomlinson, J. S., Jarnagin, W. R., DeMatteo, R. P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M. F., Blumgart, L. H., & D'Angelica, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0833 · Cited by 1,187
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, K. E., Kavanagh, B. D., Burri, S. H., Chen, C., Cardenes, H., Chidel, M. A., Pugh, T. J., Kane, M., Gaspar, L. E., & Schefter, T. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6386 · Cited by 1,082
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Weichselbaum, R. R., & Hellman, S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.44 · Cited by 945
Self-citationCopy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 654
Self-citationKorpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., & Riethmüller, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09838-0 · Cited by 479
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
Schefter, T. E., Kavanagh, B. D., Timmerman, R. D., Cardenes, H. R., Baron, A., & Gaspar, L. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.002 · Cited by 436
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
Phase II study on stereotactic body radiotherapy of colorectal metastases
Hoyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Kiil Berthelsen, A., Grau, C., Aage Engelholm, S., & Von Der Maase, H. (2006) · Acta Oncologica · doi:10.1080/02841860600904854 · Cited by 426
Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β Signaling
Gao, S., Alarcón, C., Sapkota, G., Rahman, S., Chen, P.-Y., Goerner, N., Macias, M. J., Erdjument-Bromage, H., Tempst, P., & Massagué, J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.043 · Cited by 389
Korpal, M., & Kang, Y. (2008) · RNA Biology · doi:10.4161/rna.5.3.6558 · Cited by 373
Tanvetyanon, T., Robinson, L. A., Schell, M. J., Strong, V. E., Kapoor, R., Coit, D. G., & Bepler, G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2091 · Cited by 333
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Dykxhoorn, D. M., Wu, Y., Xie, H., Yu, F., Lal, A., Petrocca, F., Martinvalet, D., Song, E., Lim, B., & Lieberman, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007181 · Cited by 324
Vrba, L., Jensen, T. J., Garbe, J. C., Heimark, R. L., Cress, A. E., Dickinson, S., Stampfer, M. R., & Futscher, B. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008697 · Cited by 285
Milano, M. T., Katz, A. W., Muhs, A. G., Philip, A., Buchholz, D. J., Schell, M. C., & Okunieff, P. (2008) · Cancer · doi:10.1002/cncr.23209 · Cited by 246
The Analysis of Gene Expression Data
(2003) · Statistics for Biology and Health · doi:10.1007/b97411 · Cited by 243
Smits, M., Nilsson, J., Mir, S. E., van der Stoop, P. M., Hulleman, E., Niers, J. M., de Witt Hamer, P. C., Marquez, V. E., Cloos, J., Krichevsky, A. M., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.205 · Cited by 236
Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., & Gilles, C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9174-0 · Cited by 227
Tryndyak, V. P., Beland, F. A., & Pogribny, I. P. (2010) · International Journal of Cancer · doi:10.1002/ijc.24972 · Cited by 224
HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R
Dvinge, H., & Bertone, P. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp578 · Cited by 223
Li, C., & Wong, W. H. (2003) · Statistics for Biology and Health · doi:10.1007/0-387-21679-0_5 · Cited by 212
Bendoraite, A., Knouf, E. C., Garg, K. S., Parkin, R. K., Kroh, E. M., O'Briant, K. C., Ventura, A. P., Godwin, A. K., Karlan, B. Y., Drescher, C. W., et al. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.08.009 · Cited by 199
Torres, L., Ribeiro, F. R., Pandis, N., Andersen, J. A., Heim, S., & Teixeira, M. R. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9317-6 · Cited by 187
Bandyopadhyay, A., Agyin, J. K., Wang, L., Tang, Y., Lei, X., Story, B. M., Cornell, J. E., Pollock, B. H., Mundy, G. R., & Sun, L.-Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3565 · Cited by 185
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
Nohata, N., Sone, Y., Hanazawa, T., Fuse, M., Kikkawa, N., Yoshino, H., Chiyomaru, T., Kawakami, K., Enokida, H., Nakagawa, M., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.213 · Cited by 176
Zheng, Y., Fischer, D. J., dos Santos, M. F., Tigyi, G., Pasteris, N. G., Gorski, J. L., & Xu, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33169 · Cited by 160
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells
Noonan, E. J., Place, R. F., Basak, S., Pookot, D., & Li, L. (2010) · Oncotarget · doi:10.18632/oncotarget.167 · Cited by 155
Lee, Y., Yang, X. H., Huang, Y., Fan, H., Zhang, Q., Wu, Y., Li, J., Hasina, R., Cheng, C., Lingen, M. W., et al. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000730 · Cited by 155
Self-citationElson‐Schwab, I., Lorentzen, A., & Marshall, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013176 · Cited by 131
Mehta, N. J., Mauer, A. M., Hellmän, S., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1677 · Cited by 115
Buck, M. B., Fritz, P., Dippon, J., Zugmaier, G., & Knabbe, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0320-03 · Cited by 100
Soond, S. M., & Chantry, A. (2011) · Oncogene · doi:10.1038/onc.2010.617 · Cited by 92
Salama, J. K., Chmura, S. J., Mehta, N., Yenice, K. M., Stadler, W. M., Vokes, E. E., Haraf, D. J., Hellmän, S., & Weichselbaum, R. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0358 · Cited by 89
Self-citationMicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis
Valastyan, S., & Weinberg, R. A. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9802 · Cited by 85
Ory, B., & Ellisen, L. W. (2011) · Oncotarget · doi:10.18632/oncotarget.244 · Cited by 50
PI3Kα Inhibitors That Inhibit Metastasis
Schmidt‐Kittler, O., Zhu, J., Yang, J., Liu, G., Hendricks, W. P. D., Lengauer, C., Gabelli, S. B., Kinzler, K. W., Vogelstein, B., Huso, D. L., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.166 · Cited by 48
Optically imageable metastatic model of human breast cancer
Li, X., Wang, J., An, Z., Yang, M., Baranov, E., Jiang, P., Sun, F., Moossa, A. R., & Hoffman, R. M. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015510207431 · Cited by 47
Time-Course Imaging of Therapeutic Functional Tumor Vascular Normalization by Antiangiogenic Agents
Zhang, Q., Bindokas, V. P., Shen, J., Fan, H., Hoffman, R. M., & Xing, H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0008 · Cited by 47
Self-citation
Cited by
Phillips, R., Shi, W. Y., Deek, M., Radwan, N., Lim, S. J., Antonarakis, E. S., Rowe, S. P., Ross, A. E., Gorin, M. A., Deville, C., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0147 · Cited by 1,159
Guckenberger, M., Lievens, Y., Bouma, A. B., Collette, L., Dekker, A., deSouza, N. M., Dingemans, A.-M. C., Fournier, B., Hurkmans, C., Lecouvet, F. E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30718-1 · Cited by 1,111
Gomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30532-0 · Cited by 1,086
Lievens, Y., Guckenberger, M., Gomez, D., Hoyer, M., Iyengar, P., Kindts, I., Méndez Romero, A., Nevens, D., Palma, D., Park, C., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.003 · Cited by 672
miR-200–containing extracellular vesicles promote breast cancer cell metastasis
Le, M. T. N., Hamar, P., Guo, C., Basar, E., Perdigão-Henriques, R., Balaj, L., & Lieberman, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75695 · Cited by 449
Metadata
- Authors
- Lussier, Y. A., Xing, H. R., Salama, J. K., Khodarev, N. N., Huang, Y., Zhang, Q., Khan, S. A., Yang, X., Hasselle, M. D., Darga, T. E., Malik, R., Fan, H., Perakis, S., Filippo, M., Corbin, K., Lee, Y., Posner, M. C., Chmura, S. J., Hellman, S., & Weichselbaum, R. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-13
- Volume
- 6
- Issue
- 12
- Pages
- e28650
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2090749716
- Cited by
- 281
- References
- 53
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.